NCT05206682View on ClinicalTrials.gov

Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect

NARecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Cesarean Section; Dehiscence
Interventions
DRUG

Leuprorelin

Leuprorelin will be used to postpone period after vaginal repair.

Trial Locations (1)

200092

RECRUITING

Shanghai Jiaotong University xinhua hospital, Shanghai

All Listed Sponsors
lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER